Literature DB >> 17348020

Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells.

Benjamin Drogat1, Marion Bouchecareilh, Sophie North, Cyril Petibois, Gérard Déléris, Eric Chevet, Andréas Bikfalvi, Michel Moenner.   

Abstract

Tumor ischemia participates in angiogenesis and cancer progression through cellular responses to hypoxia and nutrient deprivation. However, the contribution of amino acids limitation to this process remains poorly understood. Using serum-free cell culture conditions, we tested the impact of L-glutamine deprivation on metabolic and angiogenic responses in A549/8 carcinoma cells. In these cells, lowering glutamine concentration modified the cell cycle distribution and significantly induced apoptosis/necrosis. Although glutamine deprivation led to a HIF-independent increase in VEGF-A mRNA, the corresponding protein level remained low and correlated with the inhibition of protein synthesis and activation of the GCN2/eIF2alpha pathway. Limitation of glutamine availability also hampers hypoxia- and hypoglycemia-induced VEGF-A protein upregulation. Thus, glutamine deprivation may have no direct effect on VEGF-dependent angiogenesis, compared to hypoxia or to glucose deprivation, and may instead be detrimental to cancer progression by antagonizing ischemia-induced stresses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348020     DOI: 10.1002/jcp.21044

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.

Authors:  Mohamed Hassanein; Matthew R Hight; Jason R Buck; Mohammed N Tantawy; Michael L Nickels; Megan D Hoeksema; Bradford K Harris; Kelli Boyd; Pierre P Massion; H Charles Manning
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

Review 2.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 3.  Immunometabolism: A new target for improving cancer immunotherapy.

Authors:  Chunqing Guo; Shixian Chen; Wenjie Liu; Yibao Ma; Juan Li; Paul B Fisher; Xianjun Fang; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

4.  Amino acid deprivation promotes tumor angiogenesis through the GCN2/ATF4 pathway.

Authors:  Yugang Wang; Yu Ning; Goleeta N Alam; Brandon M Jankowski; Zhihong Dong; Jacques E Nör; Peter J Polverini
Journal:  Neoplasia       Date:  2013-08       Impact factor: 5.715

5.  The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.

Authors:  S Dedieu; X Canron; H R Rezvani; M Bouchecareilh; F Mazurier; R Sinisi; M Zanda; M Moenner; A Bikfalvi; S North
Journal:  BMC Med       Date:  2010-03-24       Impact factor: 8.775

Review 6.  Regulation of vascular endothelial growth factor by metabolic context of the cell.

Authors:  V B Sameer Kumar; S Binu; S J Soumya; Haritha K; P R Sudhakaran
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 7.  Altered glutamine metabolism and therapeutic opportunities for lung cancer.

Authors:  Amr Mohamed; Xingming Deng; Fadlo R Khuri; Taofeek K Owonikoko
Journal:  Clin Lung Cancer       Date:  2013-11-13       Impact factor: 4.785

8.  Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts.

Authors:  Daniela Gaglio; Chiara Soldati; Marco Vanoni; Lilia Alberghina; Ferdinando Chiaradonna
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

9.  Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.

Authors:  Moloy T Goswami; Guoan Chen; Balabhadrapatruni V S K Chakravarthi; Satya S Pathi; Sharath K Anand; Shannon L Carskadon; Thomas J Giordano; Arul M Chinnaiyan; Dafydd G Thomas; Nallasivam Palanisamy; David G Beer; Sooryanarayana Varambally
Journal:  Oncotarget       Date:  2015-09-15

Review 10.  Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.

Authors:  Vittoria Infantino; Anna Santarsiero; Paolo Convertini; Simona Todisco; Vito Iacobazzi
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.